Ranibizumab in neovascular age-related macular degeneration

Neovascular age-related macular degeneration (AMD) is a visually devastating condition resulting from choroidal neovascularization and secondary photoreceptor loss. Ranibizumab and bevacizumab are medications that target vascular endothelial growth factor (VEGF). While other therapies have demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Eng, Kenneth T, Kertes, Peter J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699647/
https://www.ncbi.nlm.nih.gov/pubmed/18046922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699647/
https://www.ncbi.nlm.nih.gov/pubmed/18046922

Ejemplares similares